Posted on June 15, 20266/15/26
The Evolving Role of Pharma 3PLs To Drive Value & Impact
Posted on June 15, 20266/15/26
The Real Cost of Delayed Pharmacovigilance (PV) Launch Readiness
Posted on June 8, 20266/8/26
Avoiding the Top 3 Pharmacovigilance Mistakes
Posted on June 8, 20266/8/26
What’s Trending in Oncology? A Discussion Following ASCO 2026 with Anne Marie Robertson
Posted on June 4, 20266/4/26
Winning in the EU JCA Era: Why Proactive Intelligence Will Define Market Access Success
Posted on June 4, 20266/4/26
Why Humans Must Be Part of the Bigger AI Picture
Posted on June 3, 20266/3/26
EVERSANA Back as Global Host and Presenting Sponsor for Frontiers Health 2026
Posted on June 1, 20266/1/26
The Stability Advantage: Why Revenue Protection is the New Standard in Commercial Deployment
Posted on May 29, 20265/29/26
U.S. Drug Pricing Is Entering a More Complex Phase
Posted on May 28, 20265/28/26